Terrie Curran
President and CEO
CEO
Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Phathom Pharmaceuticals, Inc. (PHAT) | Former President and Chief Executive Officer | $184,000 | $4,936,791 |
| 2024 | Phathom Pharmaceuticals, Inc. (PHAT) | Former President and Chief Executive Officer | $708,125 | $3,564,883 |
| 2023 | Phathom Pharmaceuticals, Inc. (PHAT) | Former President and Chief Executive Officer | $687,500 | $3,411,022 |
| 2022 | Phathom Pharmaceuticals, Inc. (PHAT) | President and Chief Executive Officer | $650,000 | $5,039,878 |
| 2021 | Phathom Pharmaceuticals, Inc. (PHAT) | President and Chief Executive Officer | $567,500 | $6,272,655 |
| 2020 | Phathom Pharmaceuticals, Inc. (PHAT) | President and Chief Executive Officer | $498,940 | $4,634,454 |
| 2019 | Phathom Pharmaceuticals, Inc. (PHAT) | President and Chief Executive Officer — | $41,667 | $3,459,096 |
Executive changes
Earnings-call appearances
-
Phathom Pharmaceuticals, Inc. Q4 FY2024 Earnings Call2025-03-06
Phathom Pharmaceuticals, Inc. (PHAT)
-
Phathom Pharmaceuticals, Inc. Q3 FY2024 Earnings Call2024-11-07
Phathom Pharmaceuticals, Inc. (PHAT)
-
Phathom Pharmaceuticals, Inc. Q2 FY2024 Earnings Call2024-08-08
Phathom Pharmaceuticals, Inc. (PHAT)
-
Phathom Pharmaceuticals, Inc. Q1 FY2024 Earnings Call2024-05-09
Phathom Pharmaceuticals, Inc. (PHAT)
-
Phathom Pharmaceuticals, Inc. Q4 FY2023 Earnings Call2024-03-07
Phathom Pharmaceuticals, Inc. (PHAT)